Tilray Becomes First Company Authorized to Distribute Branded Medical Marijuana Flower in Italy

Beginning this month, Tilray-branded flower is available for distribution to pharmacies nationwide through its subsidiary, FL Group. Three products have been approved for therapeutic use: Tilray THC 25%, Tilray THC 18%, and Tilray THC 9% / CBD 9%.

“This milestone underscores the vital role of medical cannabis as a therapeutic medicine for patients in need, supporting their health and well-being,” said Denise Faltischek, Tilray’s Chief Strategy Officer and Head of International. She credited the Italian government for establishing a regulatory framework that ensures patient access to safe and consistent cannabinoid-based therapies. The products are produced in EU-GMP certified facilities and are part of Tilray’s broader European expansion. The company now has medical cannabis operations in Germany, Italy, Portugal, Poland, and the United Kingdom, offering a wide array of products for patients with qualifying conditions.

Tilray Medical, a division of Tilray Brands, was among the first licensed producers in Canada and has since built certified production hubs in Portugal and Germany. The company distributes several well-known brands, including Broken Coast, Redecan, and Good Supply.

This development further cements Tilray’s position as a leader in the European medical marijuana market and marks a major step forward for patients in Italy who rely on therapeutic cannabis.